Quantification of endocannabinoids in rat biological samples by GC/MS: Technical and theoretical considerations

Sarah Hardison, Susan T. Weintraub, Andrea Giuffrida

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

In the last several years, interest has increased significantly about the endocannabinoids anandamide and 2-arachidonylglycerol, two lipid messengers that activate cannabinoid receptors. Quantification of these compounds in biological samples presents numerous technical challenges. Because of their low abundance, endocannabinoids are usually quantified by isotope dilution assays using mass spectrometry coupled to either gas chromatography or high-performance liquid chromatography. Although endocannabinoid levels in biological fluids, such as plasma and cerebrospinal fluid, can be directly determined by these techniques, the complex lipid profile of brain tissue samples mandates purification of lipid extracts before GC/MS analysis; this step is not necessary when using HPLC/MS. We have found that when silica gel chromatography is used for endocannabinoid purification, poor recovery and loss of deuterium from the internal standards lead to inaccurate estimation of endocannabinoid levels. By contrast, purification strategies using C18 solid-phase extraction permits precise and reproducible GC/MS quantification of endocannabinoids in tissue samples.

Original languageEnglish
Pages (from-to)106-112
Number of pages7
JournalProstaglandins & Other Lipid Mediators
Volume81
Issue number3-4
Early online date20 Sep 2006
DOIs
Publication statusPublished - 1 Dec 2006

Fingerprint

Endocannabinoids
Rats
Purification
Lipids
High Pressure Liquid Chromatography
Tissue
Cerebrospinal fluid
Cannabinoid Receptors
Deuterium
Silica Gel
Solid Phase Extraction
High performance liquid chromatography
Chromatography
Isotopes
Gas chromatography
Gas Chromatography
Dilution
Gel Chromatography
Mass spectrometry
Cerebrospinal Fluid

Keywords

  • 2-Arachidonylglycerol
  • Anandamide
  • Gas chromatography
  • Lipids
  • Mass spectrometry
  • Solid-phase extraction

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Quantification of endocannabinoids in rat biological samples by GC/MS : Technical and theoretical considerations. / Hardison, Sarah; Weintraub, Susan T.; Giuffrida, Andrea.

In: Prostaglandins & Other Lipid Mediators, Vol. 81, No. 3-4, 01.12.2006, p. 106-112.

Research output: Contribution to journalArticle

Hardison, Sarah ; Weintraub, Susan T. ; Giuffrida, Andrea. / Quantification of endocannabinoids in rat biological samples by GC/MS : Technical and theoretical considerations. In: Prostaglandins & Other Lipid Mediators. 2006 ; Vol. 81, No. 3-4. pp. 106-112.
@article{3a90bf6d06944f8b9e874a7ad1dfb2b0,
title = "Quantification of endocannabinoids in rat biological samples by GC/MS: Technical and theoretical considerations",
abstract = "In the last several years, interest has increased significantly about the endocannabinoids anandamide and 2-arachidonylglycerol, two lipid messengers that activate cannabinoid receptors. Quantification of these compounds in biological samples presents numerous technical challenges. Because of their low abundance, endocannabinoids are usually quantified by isotope dilution assays using mass spectrometry coupled to either gas chromatography or high-performance liquid chromatography. Although endocannabinoid levels in biological fluids, such as plasma and cerebrospinal fluid, can be directly determined by these techniques, the complex lipid profile of brain tissue samples mandates purification of lipid extracts before GC/MS analysis; this step is not necessary when using HPLC/MS. We have found that when silica gel chromatography is used for endocannabinoid purification, poor recovery and loss of deuterium from the internal standards lead to inaccurate estimation of endocannabinoid levels. By contrast, purification strategies using C18 solid-phase extraction permits precise and reproducible GC/MS quantification of endocannabinoids in tissue samples.",
keywords = "2-Arachidonylglycerol, Anandamide, Gas chromatography, Lipids, Mass spectrometry, Solid-phase extraction",
author = "Sarah Hardison and Weintraub, {Susan T.} and Andrea Giuffrida",
year = "2006",
month = "12",
day = "1",
doi = "10.1016/j.prostaglandins.2006.08.002",
language = "English",
volume = "81",
pages = "106--112",
journal = "Prostaglandins & Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier BV",
number = "3-4",

}

TY - JOUR

T1 - Quantification of endocannabinoids in rat biological samples by GC/MS

T2 - Technical and theoretical considerations

AU - Hardison, Sarah

AU - Weintraub, Susan T.

AU - Giuffrida, Andrea

PY - 2006/12/1

Y1 - 2006/12/1

N2 - In the last several years, interest has increased significantly about the endocannabinoids anandamide and 2-arachidonylglycerol, two lipid messengers that activate cannabinoid receptors. Quantification of these compounds in biological samples presents numerous technical challenges. Because of their low abundance, endocannabinoids are usually quantified by isotope dilution assays using mass spectrometry coupled to either gas chromatography or high-performance liquid chromatography. Although endocannabinoid levels in biological fluids, such as plasma and cerebrospinal fluid, can be directly determined by these techniques, the complex lipid profile of brain tissue samples mandates purification of lipid extracts before GC/MS analysis; this step is not necessary when using HPLC/MS. We have found that when silica gel chromatography is used for endocannabinoid purification, poor recovery and loss of deuterium from the internal standards lead to inaccurate estimation of endocannabinoid levels. By contrast, purification strategies using C18 solid-phase extraction permits precise and reproducible GC/MS quantification of endocannabinoids in tissue samples.

AB - In the last several years, interest has increased significantly about the endocannabinoids anandamide and 2-arachidonylglycerol, two lipid messengers that activate cannabinoid receptors. Quantification of these compounds in biological samples presents numerous technical challenges. Because of their low abundance, endocannabinoids are usually quantified by isotope dilution assays using mass spectrometry coupled to either gas chromatography or high-performance liquid chromatography. Although endocannabinoid levels in biological fluids, such as plasma and cerebrospinal fluid, can be directly determined by these techniques, the complex lipid profile of brain tissue samples mandates purification of lipid extracts before GC/MS analysis; this step is not necessary when using HPLC/MS. We have found that when silica gel chromatography is used for endocannabinoid purification, poor recovery and loss of deuterium from the internal standards lead to inaccurate estimation of endocannabinoid levels. By contrast, purification strategies using C18 solid-phase extraction permits precise and reproducible GC/MS quantification of endocannabinoids in tissue samples.

KW - 2-Arachidonylglycerol

KW - Anandamide

KW - Gas chromatography

KW - Lipids

KW - Mass spectrometry

KW - Solid-phase extraction

UR - http://www.scopus.com/inward/record.url?scp=33750495827&partnerID=8YFLogxK

U2 - 10.1016/j.prostaglandins.2006.08.002

DO - 10.1016/j.prostaglandins.2006.08.002

M3 - Article

VL - 81

SP - 106

EP - 112

JO - Prostaglandins & Other Lipid Mediators

JF - Prostaglandins & Other Lipid Mediators

SN - 1098-8823

IS - 3-4

ER -